Effects of drospirenone-ethinylestradiol and/or metformin on CD4(+)CD28(null) T lymphocytes frequency in women with hyperinsulinemia having polycystic ovary syndrome: a randomized clinical trial

Francesca Moro, Andrea Morciano, Anna Tropea, Francesca Sagnella, Giovanna Liuzzo, Elisa Scarinci, Andrea Ciardulli, Daniela Martinez, Alessandra Familiari, Giovanna Liuzzo, Alessandra Tritarelli, Nicola Cosentino, Giampaolo Niccoli, Filippo Crea, Antonio Lanzone, Rosanna Apa

Risultato della ricerca: Contributo in rivistaArticolo in rivista

14 Citazioni (Scopus)

Abstract

To evaluate the long-term effects of drospirenone (DRSP)/ethinylestradiol (EE) alone, metformin alone, and DRSP/EE-metformin on CD4(+)CD28(null) T lymphocytes frequency, a cardiovascular risk marker, in patients with hyperinsulinemic polycystic ovary syndrome (PCOS).
Lingua originaleEnglish
pagine (da-a)1508-1517
Numero di pagine10
RivistaReproductive Sciences
Volume20
DOI
Stato di pubblicazionePubblicato - 2013

Keywords

  • CD4+CD28null T-lymphocytes
  • drospirenone
  • ethinylestradiol
  • metformin
  • polycystic ovary syndrome

Fingerprint

Entra nei temi di ricerca di 'Effects of drospirenone-ethinylestradiol and/or metformin on CD4(+)CD28(null) T lymphocytes frequency in women with hyperinsulinemia having polycystic ovary syndrome: a randomized clinical trial'. Insieme formano una fingerprint unica.

Cita questo